Jakko van Ingen - Concepedia

Author

Jakko van Ingen

Also Known As

Armand Van Deun, Hempstead, Sarah E., J van Ingen, J. Van Ingen, J. van Ingen, JAKKO VAN INGEN, Jakko Ingen, Jakko Van Ingen, Jakko van Ingen, Jan van Ingen

394

Publications

18.6K

Citations

H-Index

114

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center National Institute for Public Health and the Environment University of Colorado Denver National Jewish Health

About

Jakko van Ingen is an author at Radboud University Nijmegen specializing in medicine, clinical microbiology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	72	7.3K
2	Health Sciences	14	15	1.4K
3	Engineering	3	3	120
4	Natural Sciences	2	2	162
5	Education	1	1	21

Jakko van Ingen

156

Publications

13.4K

Citations

H-Index

Page 1

	Year	Citations
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study Wouter Hoefsloot, Jakko van Ingen, Claire Andréjak, European Respiratory Journal	2013	835
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Charles L. Daley, Jonathan M. Iaccarino, Christoph Lange, European Respiratory Journal	2020	808
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline Charles L. Daley, Jonathan M. Iaccarino, Christoph Lange, Clinical Infectious Diseases Pulmonary TuberculosisPulmonary CareMycobacterium AbscessusAdvanced Lung DiseasePathology	2020	770
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline Charles L. Daley, Jonathan M. Iaccarino, Christoph Lange, Clinical Infectious Diseases Pulmonary TuberculosisPulmonary CareMycobacterium AbscessusAdvanced Lung DiseasePathology	2020	739
Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium Josephine M. Bryant, Dorothy Grogono, Daniela Rodriguez-Rincon, Science Medical MicrobiologyAntimicrobial Resistance GenePathogenic MicrobiologyMycobacterium AbscessusHealth Sciences	2016	576
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis R. Andrés Floto, Kenneth N. Olivier, Lisa Saiman, Thorax Pulmonary TuberculosisEpidemiologyPreventive MedicineAdvanced Lung DiseaseTuberculosis Prevention	2015	459
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary R. Andrés Floto, Kenneth N. Olivier, Lisa Saiman, Thorax Pulmonary TuberculosisEpidemiologyConsensus RecommendationsPulmonary PathologyAdvanced Lung Disease	2015	458
BCG Vaccination in Humans Elicits Trained Immunity via the Hematopoietic Progenitor Compartment Branko Cirovic, L. Charlotte J. de Bree, Laszlo Groh, Cell Host & Microbe VaccinationBcg VaccinationVaccine DevelopmentTrained ImmunityVaccine Target	2020	453
ESX‐1‐mediated translocation to the cytosol controls virulence of mycobacteria Caroline Demangel, Jakko van Ingen, Jorge Pérez, Cellular Microbiology Pathogenic MicrobiologyMicrobial PathogensBacteriologyImmunologyBacterial Pathogens	2012	408
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by <i>Mycobacterium avium</i> Complex (CONVERT). A Prospective, Open-Label, Randomized Study David E. Griffith, Gina Eagle, Rachel Thomson, American Journal of Respiratory and Critical Care Medicine	2018	328

Page 1